tobramycin has been researched along with Hematologic Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, VW; Binder, C; Binder, L; Erichsen, N; Hiddemann, W; Menke, CF; Oellerich, M; Schiel, X; Schüttrumpf, S; Unterhalt, M | 1 |
| Hatanaka, K; Hiraoka, A; Hosen, N; Karasuno, T; Kawamoto, S; Masaoka, T; Nakamura, H; Nakao, T; Teshima, H; Ujiie, H; Yagi, T | 1 |
| Abe, T; Fukuda, M; Hirashima, K; Karasawa, M; Miura, Y; Moriyama, Y; Motoyoshi, K; Nagata, N; Naruse, T; Ninomiya, H; Oh, H; Saito, K; Shibata, A; Shishido, H; Yoshida, M | 1 |
| Baudard, M; Bouvet, A; Chast, F; Delmer, A; Legrand, O; Levy, V; Marie, JP; Marjanovic, Z; Rio, B; Vekhoff, A; Zittoun, R | 1 |
3 trial(s) available for tobramycin and Hematologic Neoplasms
| Article | Year |
|---|---|
[New quinolone versus vancomycin/tobramycin for intestinal sterilization in patients who undergo allogeneic bone marrow transplantation].
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Bone Marrow Transplantation; Child; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Intestines; Middle Aged; Quinolones; Sterilization; Tobramycin; Transplantation Conditioning; Vancomycin | 1999 |
Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
Topics: Adolescent; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Female; Fever; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Immunocompromised Host; Lenograstim; Leukocyte Count; Male; Middle Aged; Neutropenia; Pneumonia; Recombinant Proteins; Tobramycin; Treatment Outcome | 1999 |
Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Bacterial Infections; Case-Control Studies; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Tazobactam; Tobramycin; Vancomycin | 1999 |
1 other study(ies) available for tobramycin and Hematologic Neoplasms
| Article | Year |
|---|---|
Clinical outcome and economic impact of aminoglycoside peak concentrations in febrile immunocompromised patients with hematologic malignancies.
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cephalosporins; Drug Monitoring; Female; Fever; Gentamicins; Hematologic Neoplasms; Humans; Male; Middle Aged; Penicillins; Prognosis; Tobramycin | 1998 |